mja.com.au | The Medical Journal of Australia

Home | Issues | MJA shop | MJA Careers | Contact | Topics | Search | RSS  | Login | Buy full access

Letters

The hidden cost of varicella

Elizabeth K Nairn, Joshua Wolf and Jim P Buttery
MJA 2009; 190 (4): 223-224

A 5-month-old boy with known congenital varicella syndrome presented to our hospital emergency department with generalised herpes zoster (shingles).

The child was born in Australia. His Sri Lankan-born mother had developed chickenpox in the second trimester of pregnancy. Examination and investigation of the child at birth for complications of congenital varicella syndrome had revealed only skin changes on the left thigh (Box, A).

A new vesicular rash had evolved over 3 days, initially involving right T8 (Box, B) and L4–5 (Box, C) dermatomes, then progressing to cover the entire body. There was no clinical evidence of visceral involvement. Cicatricial scarring had replaced the congenital skin changes (Box, D).

Varicella zoster virus was isolated from vesicular fluid. Oral valaciclovir was prescribed for 7 days because the generalised nature of the rash demonstrated an insufficient immune response to varicella reactivation. The symptoms rapidly resolved, with no new scarring.

A maternal chickenpox infection during pregnancy can be severe and life-threatening, and can also cause in-utero infection, which may be fatal or result in congenital abnormalities.1

Important features of congenital varicella syndrome include:

Shingles is caused by reactivation of varicella zoster virus. Childhood shingles is uncommon (incidence, 0.05%/year), rarely indicates primary immunodeficiency,2 and occurs more frequently following congenital infection (4.4%/year)2 or chickenpox infection during infancy (0.4%/year).2 Antiviral treatment of shingles in immunocompetent young children is not usually recommended, as complications (including post-herpetic neuralgia) are rare.3

Chickenpox has been mainly a childhood disease in Australia, but in many tropical countries it predominantly affects adults. Immigrants to Australia from these regions (including the mother of our patient) may remain susceptible to varicella infection.4 At least 5% of Australian women of childbearing age were born in tropical countries.5

Varicella vaccine is highly effective and is listed on the National Immunisation Program Schedule6 for childhood immunisation. Lowering the community prevalence of varicella infection by routine childhood immunisation can help protect non-immune adults and immunocompromised patients.1 Opportunistic, proactive identification and immunisation of non-immune adults, particularly for both prospective parents before pregnancy, could help prevent serious consequences.

Cicatricial scarring and shingles in a 5-month-old infant with congenital varicella syndrome

Elizabeth K Nairn, Paediatric Resident1Joshua Wolf, Infectious Diseases Fellow1,2Jim P Buttery, Infectious Diseases Physician1,2,3

1 Infectious Diseases Unit, Department of General Medicine, Royal Childrens Hospital, Melbourne, VIC.

2 Department of Paediatrics, University of Melbourne, Melbourne, VIC.

3 Murdoch Childrens Research Institute, Melbourne, VIC.

joshua.wolfATrch.org.au

  1. Tan MP, Koren G. Chickenpox in pregnancy: revisited. Reprod Toxicol 2006; 21: 410-420. <PubMed>
  2. Feder HM Jr, Hoss DM. Herpes zoster in otherwise healthy children. Pediatr Infect Dis J 2004; 23: 451-457. <PubMed>
  3. Pickering LK, editor. Red book: 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Grove, Ill: American Academy of Pediatrics, 2006.
  4. MacMahon E, Brown LJ, Bexley S, et al. Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study. BMJ 2004; 329: 551-552. <PubMed>
  5. Australian Bureau of Statistics. 2006 census of population and housing: country of birth of person by age and sex. http://www.censusdata.abs.gov.au (accessed Nov 2008).
  6. Australian Department of Health and Ageing. National Immunisation Program (NIP) Schedule. http://www.health.gov.au/internet/immunise/publishing.nsf/content/nips (accessed Jan 2009).

(Received 14 Aug 2008, accepted 9 Dec 2008)


Home | Issues | MJA shop | Terms of use | MJA Careers | More... | Contact | Topics | Search | RSS 

mja.com.au | The Medical Journal of Australia  

©The Medical Journal of Australia 2009 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377